Indication
Treatment of rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, psoriasis and ulcerative colitis
Loading your page…
Loading your page…
Marketing Authorisation Holder: Amgen Europe B.V.
INN: infliximab
AI Drug & Interaction Analysis
Free account required
Ask Osler about ABP 710: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.